Featured Research

from universities, journals, and other organizations

Researchers move closer to identifying new class of asthma, COPD drugs

Date:
May 15, 2011
Source:
American Thoracic Society
Summary:
Researchers in Baltimore have identified new compounds which relax airway muscles and may provide relief from shortness of breath for patients with COPD and asthma. The bitter-tasting compounds are at least as, if not more, effective than currently available agents used to manage these diseases, and may present new options for treatment.

Researchers in Baltimore have identified new compounds whichrelax airway muscles and may provide relief from shortness of breath for patients with COPD and asthma. The bitter-tasting compounds are at least as, if not more, effective than currently available agents used to manage these diseases, and may present new options for treatment.

The study was presented at the ATS 2011 International Conference in Denver.

"We have identified compounds that are more potent than our previously identified set of compounds, paving the way for development of bronchodilators for treating asthma and COPD," said study author Kathryn Robinett, MD, pulmonary and critical care fellow at the University of Maryland School of Medicine. "These compounds represent a new class of bronchodilator that work through an entirely different mechanism than beta-agonists like albuterol, salmeterol and formoterol."

Bitter taste receptors on taste buds of the tongue are thought to have evolved to warn people that they may be ingesting a toxic substance, Dr. Robinett explained. Previous studies revealed these receptors are also present on the smooth muscle surrounding the airways, which constricts in patients with asthma and COPD, reducing the size of the airway and making breathing difficult.

"We had been looking for airway smooth muscle receptors that, when activated, can relax this muscle for the past five years, and we were excited to find compounds that caused profound relaxation, in both mouse and human airways," she said.

For their study, the researchers examined compounds known to be bitter suggesting they may be effective in relaxing these airway muscles. Once potential compounds were identified, the researchers administered these compounds to mouse airways to examine their effects.

They found that bitter compounds were at least as effective as beta-agonists in relaxing smooth airway muscle. Relaxation of active tension in these muscles in mice approached 100 percent for most compounds, compared to 30 percent for the beta-agonist isoproterenol. In a more limited number of studies in human airways, they continue to find bitter compounds to be somewhat more effective than beta-agonists. More importantly, they appear to work in different ways inside the cell, so the two classes of drugs can work together to treat moderate to severe obstructive lung disease.

"These findings continue to support data that bitter taste receptor agonists could be the next major class of therapeutics in treating asthma and chronic obstructive pulmonary disease," Dr. Robinett said.

Obstructive lung disease, including asthma and COPD, continues to be a significant source of morbidity and mortality affecting 300 million people worldwide.

"Unfortunately, despite widespread use of inhaled corticosteroids and long acting beta-agonists, and environmental controls, as many as one-half of people in the U.S. alone have inadequate control of asthma," Dr. Robinett said. "Bitter taste receptor agonists may add to our armamentarium of treatment options."

Despite their impressive efficacy, the researchers found many of the compounds activate only one or two of the six main bitter taste receptors on airway smooth muscle, meaning that they may not taste very bitter on the tongue, which has 25 bitter receptors.

"We continue to be amazed at the breadth of substances that activate these receptors," Dr. Robinett said. "The plant world is packed with agents that can be effective therapeutics at these targets, or can provide us with the 'molecular backbone' to synthesize compounds that would be better drugs."

Dr. Robinett said this study is just the first step in a much larger task: identifying the compounds which offer optimal results for COPD and asthmatic patients.

"There are over 10,000 compounds that are known to be bitter taste receptor agonists," she said. "These come from plants, including medicinal herbs and food additives, or are synthetic agents that are used for entirely different medical reasons (such as chloroquine for treating malaria). So, we have not only uncovered a previously unrecognized way to open the airways in asthma and COPD, but we have many compounds to consider either 'as they are,' or as backbones for synthesizing a new agent.

"Our challenge, then," Dr. Robinett continued, "is to find safe agents that are not so bitter-tasting as to make them unpalatable, and yet are able to affect the degree of relaxation of airway smooth-muscle that we have found in experimental models.

"Our immediate focus is to gain a better understanding of second messenger pathways and desensitization of bitter taste receptors, to continue to search for more agonists, and to carry out toxicology studies on selected compounds," Dr. Robinett said. "Then, with a set of our 'best compounds' we will begin the process for Phase 1 clinical trials."


Story Source:

The above story is based on materials provided by American Thoracic Society. Note: Materials may be edited for content and length.


Cite This Page:

American Thoracic Society. "Researchers move closer to identifying new class of asthma, COPD drugs." ScienceDaily. ScienceDaily, 15 May 2011. <www.sciencedaily.com/releases/2011/05/110515122501.htm>.
American Thoracic Society. (2011, May 15). Researchers move closer to identifying new class of asthma, COPD drugs. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2011/05/110515122501.htm
American Thoracic Society. "Researchers move closer to identifying new class of asthma, COPD drugs." ScienceDaily. www.sciencedaily.com/releases/2011/05/110515122501.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins